Overview

Novel Window of Opportunity Trial to Evaluate the Impact of Statins to Oppose Prostate Cancer

Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
This research study provides a novel opportunity to examine the intra-prostatic tumour inhibitory effects of statins in men with prostate cancer undergoing surgery.
Phase:
Phase 2
Details
Lead Sponsor:
University Health Network, Toronto
Treatments:
Fluvastatin